Sponsor Dossier
Asteri Pharma
Sponsor Dossier for Asteri Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: CAPRELSA
- Brand: INCRELEX
- Brand: METOPIRONE
- Brand: TEGLUTIK
About
Asteri Pharma is an Australian Private Company with ABN 69665948158, registered in Victoria. The entity is Active.
Portfolio
Asteri Pharma has 4 brands on the ARTG, of which 4 are indexable and 4 carry a Product Information document. 2 brands are PBS-listed, 2 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include CAPRELSA, INCRELEX, METOPIRONE, TEGLUTIK.
Therapeutic focus
— Endocrinology: 2 brands — Neurology: 1 brand — Oncology: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 2 brands with a PBAC outcome on record. The latest AusPAR is 2020-03-12, across 1 brand with an AusPAR on record.